HARRT for life.

Research output: Contribution to journalArticle

Abstract

Combination therapy for HIV can reduce viral loads to undetectable levels, and although there was once optimism that undetectable viral loads would lead to viral eradication, studies have shown that HIV persists in some cell types. As a result, patients on antiretroviral therapy can expect to continue treating their HIV as a chronic illness, and are cautioned that those who stop taking their drugs may experience a viral rebound. When people are on effective antiviral therapy, the latent virus in the body is not causing more damage to the immune system.

Original languageEnglish (US)
Pages (from-to)2
Number of pages1
JournalThe Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service
Volume11
Issue number4
StatePublished - 1999
Externally publishedYes

Fingerprint

HIV
Viral Load
Antiviral Agents
Immune System
Chronic Disease
Therapeutics
Viruses
Pharmaceutical Preparations
Optimism

Cite this

@article{6d01388ceefe46fd8dfdd140d10473cb,
title = "HARRT for life.",
abstract = "Combination therapy for HIV can reduce viral loads to undetectable levels, and although there was once optimism that undetectable viral loads would lead to viral eradication, studies have shown that HIV persists in some cell types. As a result, patients on antiretroviral therapy can expect to continue treating their HIV as a chronic illness, and are cautioned that those who stop taking their drugs may experience a viral rebound. When people are on effective antiviral therapy, the latent virus in the body is not causing more damage to the immune system.",
author = "Siliciano, {Robert F}",
year = "1999",
language = "English (US)",
volume = "11",
pages = "2",
journal = "The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service",
issn = "1551-8396",
publisher = "Johns Hopkins University Press",
number = "4",

}

TY - JOUR

T1 - HARRT for life.

AU - Siliciano, Robert F

PY - 1999

Y1 - 1999

N2 - Combination therapy for HIV can reduce viral loads to undetectable levels, and although there was once optimism that undetectable viral loads would lead to viral eradication, studies have shown that HIV persists in some cell types. As a result, patients on antiretroviral therapy can expect to continue treating their HIV as a chronic illness, and are cautioned that those who stop taking their drugs may experience a viral rebound. When people are on effective antiviral therapy, the latent virus in the body is not causing more damage to the immune system.

AB - Combination therapy for HIV can reduce viral loads to undetectable levels, and although there was once optimism that undetectable viral loads would lead to viral eradication, studies have shown that HIV persists in some cell types. As a result, patients on antiretroviral therapy can expect to continue treating their HIV as a chronic illness, and are cautioned that those who stop taking their drugs may experience a viral rebound. When people are on effective antiviral therapy, the latent virus in the body is not causing more damage to the immune system.

UR - http://www.scopus.com/inward/record.url?scp=0033156641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033156641&partnerID=8YFLogxK

M3 - Article

C2 - 11366922

AN - SCOPUS:0033156641

VL - 11

SP - 2

JO - The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service

JF - The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service

SN - 1551-8396

IS - 4

ER -